๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Randomized trial of two different doses of pyridoxine in the prevention of capecitabine-associated palmar-plantar erythrodysesthesia

โœ Scribed by T CHALERMCHAI; K TANTIPHLACHIVA; H SUWANRUSME; N VORAVUD; V SRIURANPONG

Book ID
111318825
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
104 KB
Volume
6
Category
Article
ISSN
1743-7555

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Randomized multicenter Phase II trial of
Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma
โœ Emilio Bajetta; Maria Di Bartolomeo; Luigi Mariani; Antonio Cassata; Salvatore A ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 124 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND The aim of the current randomized Phase II study was to investigate the efficacy and safety of capecitabine combined with irinotecan as firstโ€line treatment in metastatic colorectal carcinoma (CRC). ## METHODS A total of 140 patients received capecitabine at a dose of 1

A multi-centre randomized trial of two d
A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset Type 1 diabetes (the IMDIAB VI)
โœ Natalia Visalli; Maria G. Cavallo; Alberto Signore; Marco G. Baroni; Raffaella B ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 70 KB ๐Ÿ‘ 1 views

Background Intensive insulin therapy is the gold standard by which Type 1 diabetes is treated. In addition to this therapy, administration of nicotinamide (NA) can be beneยฎcial. This concept is reinforced by the results of a recent meta-analysis of the use of NA in patients with recent-onset Type 1